Oslo, 27 September 2013. PCI Biotech (PCIB) will present the company at SACHS Associates 13th Annual Biotech in Europe Investor Forum at Hilton Zurich Airport Hotel, Switzerland.
The presentation will be held 30th September at 5.30pm in Panorama A and the company will be represented by Dr. Per Walday, CEO and Mr. Gael L'Hévéder, Head of Business Development.
For more information, please contact:
Bernt-Olav Røttingsnes, CFO, bor@pcibiotech.no, Mobile: +47 913 47 021
This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.